Vita Life Sciences Limited
VLS.AX News Today: Stay Updated with the Latest Vita Life Sciences Limited News in Real Time
Find VLS.AX news now at Meyka AI. Stay informed with the latest Vita Life Sciences Limited stocks updates, including price news, market analysis, and expert insights.

Galaxus Crypto Assets Face Regulatory Scrutiny in Switzerland, May 27
Swiss regulators scrutinize Galaxus crypto assets. GALAUSD falls 0.3%, GALAXYUSD down 85%, GALEONUSD drops 2.6% amid compliance concerns.

Galaxus Crypto Assets Tumble on May 27: GALAUSD Falls 0.3%
Galaxus crypto tokens weaken May 27: GALAUSD -0.3% to $0.00327, GALEONUSD -2.58% to $0.00603. Technical analysis shows oversold conditions.

Maine Senate Candidate Platner Faces Backlash Over Deleted Posts Mocking Veterans, May 27
Maine Democratic Senate candidate Graham Platner faces backlash over deleted Reddit posts mocking a Purple Heart veteran and Chris Kyle.

Coal India OFS Opens May 27: Government Sells 2% Stake at βΉ412 Floor Price
Government divests 2% Coal India stake via OFS at βΉ412 floor price, targeting βΉ5,000 crore. Bidding: May 27 (non-retail), May 29 (retail).

Solana USD Falls 1.44% Daily: SOLUSD at $83.68
SOLUSD drops 1.44% to $83.68 with weak momentum. RSI at 43.82 signals neutral conditions. Forecast targets $209.33 yearly.

Vedanta Demerger Nears Completion: 4 New Companies to List by June
Vedantaβs five-way demerger nears completion with four new companies listing by June 2026. Shareholders receive 1:1 share allotment.

Singapore Bankruptcy Cases Jump 27% in Q1 2026, May 27
Singapore personal bankruptcy cases rose 27% to 482 in Q1 2026 from 378 in Q1 2025, reflecting deepening regional debt pressures.

Lufthansa Cuts 2,480 Winter Flights on Middle East Turmoil, May 27
Lufthansa cancels 2,480 winter flights Oct 2026-Mar 2027 due to Middle East conflict and fuel costs. Refunds or rebooking available.

Tesla Stock Rises 1.8% on SpaceX IPO Buzz, May 27
Tesla stock rises 1.8% to $433.59 amid SpaceX IPO buzz. Meyka rates TSLA B- with $395.45 target. Analyst consensus neutral.